{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:53:42Z","timestamp":1774313622009,"version":"3.50.1"},"reference-count":89,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Osteoporosis is currently receiving increasing attention as an important late effect in survivors of childhood cancer and its treatment because of their quality of life and its negative effect on the survivors' ability to perform developmentally appropriate activities. Survivors of childhood cancer are especially vulnerable because they are affected during childhood and adolescence, a time when peak bone mass should be achieved. This paper reviews decreased bone density in acute lymphoblastic leukemia (ALL), which is the most common childhood cancer and has a cure rate approaching 80%. Osteopenia\/osteoporosis has been observed in all phases of the disease: at diagnosis, during treatment, and throughout the post-treatment period for as long as 20 years. Among the findings that have been described are musculoskeletal pain, disturbed gait, fractures, kyphosis, lordosis, and growth failure. Risk factors not specifically related to ALL include smoking, ingestion of carbonated beverages, and family history of \u201cbrittle bone\u201d or fractures. Patients should be counseled in regard to diet, exercise, smoking cessation, and avoidance of carbonated beverages. There are a number of options for specific drug therapy; however, the administration of bisphosponates to children and adolescents must be approached with caution. Research is needed to determine how extensive the problem is and how to best prevent and treat the osteopenia\/osteoporosis associated with ALL.<\/jats:p>","DOI":"10.1634\/theoncologist.6-3-278","type":"journal-article","created":{"date-parts":[[2004,8,24]],"date-time":"2004-08-24T21:38:39Z","timestamp":1093383519000},"page":"278-285","source":"Crossref","is-referenced-by-count":81,"title":["Osteoporosis in Survivors of Acute Lymphoblastic Leukemia"],"prefix":"10.1093","volume":"6","author":[{"given":"Theresa B.","family":"Haddy","sequence":"first","affiliation":[{"name":"Department of Hematology-Oncology, Children's National Medical Center, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Revonda B.","family":"Mosher","sequence":"additional","affiliation":[{"name":"Department of Hematology-Oncology, Children's National Medical Center, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory H.","family":"Reaman","sequence":"additional","affiliation":[{"name":"Department of Hematology-Oncology, Children's National Medical Center, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,6,1]]},"reference":[{"key":"2021122210294563000_R1","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1200\/JCO.1998.16.8.2864","article-title":"Programs for adult survivors of childhood cancer","volume":"16","author":"Oeffinger","year":"1998","journal-title":"J Clin Oncol"},{"key":"2021122210294563000_R2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00043426-199705000-00007","article-title":"Methods for tracing, contacting, and recruiting a cohort of survivors of childhood cancer","volume":"19","author":"Mertens","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021122210294563000_R3","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1200\/JCO.1998.16.6.2070","article-title":"Late effects in long-term survivors of high-grade non-Hodgkin's lymphomas","volume":"16","author":"Haddy","year":"1998","journal-title":"J Clin Oncol"},{"key":"2021122210294563000_R4","first-page":"72","article-title":"Late effects in survivors of bone tumors","volume":"15","author":"Mosher","year":"1998","journal-title":"J Pediatr Oncol Nurs"},{"key":"2021122210294563000_R5","article-title":"Health lifestyles, risk-taking behavior, and outlook of long-term survivors of non-Hodgkin's lymphomas","volume-title":"Int J Pediatr Hematol Oncol","author":"Haddy"},{"key":"2021122210294563000_R6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00043426-200005000-00006","article-title":"Childhood cancer: a 4-year prospective study of the psychological adjustment of children and parents","volume":"22","author":"Sawyer","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021122210294563000_R7","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/(SICI)1097-0142(19960915)78:6<1330::AID-CNCR23>3.0.CO;2-0","article-title":"Quality of life research in childhood cancer: the time is now","volume":"78","author":"Reaman","year":"1996","journal-title":"Cancer"},{"key":"2021122210294563000_R8","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1687::AID-CNCR24>3.0.CO;2-M","article-title":"Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting","volume":"88","author":"Oeffinger","year":"2000","journal-title":"Cancer"},{"key":"2021122210294563000_R9","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/ard.55.10.700","article-title":"Current and potential future drug treatments for osteoporosis","volume":"55","author":"Patel","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"2021122210294563000_R10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0009-9120(97)00113-6","article-title":"Biochemical markers of bone metabolism: an overview","volume":"30","author":"Christenson","year":"1997","journal-title":"Clin Biochem"},{"key":"2021122210294563000_R11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1096-911X(199904)32:4<272::AID-MPO6>3.0.CO;2-G","article-title":"Osteopenia in young adult survivors of childhood cancer","volume":"32","author":"Vassilopoulou-Sellin","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"2021122210294563000_R12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/adc.80.2.143","article-title":"Reduced bone density at completion of chemotherapy for a malignancy","volume":"80","author":"Arikoski","year":"1999","journal-title":"Arch Dis Child"},{"key":"2021122210294563000_R13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00043426-199905000-00017","article-title":"Bone mineral density in survivors of cancer in childhood [letter]","volume":"21","author":"Barr","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021122210294563000_R14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00043426-199807000-00008","article-title":"Longitudinal evaluation of bone mineral density in children receiving chemotherapy","volume":"20","author":"Henderson","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021122210294563000_R15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00043426-199805000-00010","article-title":"Bone mineral density in young adult survivors of childhood cancer","volume":"20","author":"Aisenberg","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021122210294563000_R16","first-page":"770","article-title":"Osteoporosis in survivors of childhood malignancy [editorial]","volume":"34","author":"Leiper","year":"1998","journal-title":"Eur J Cancer"},{"key":"2021122210294563000_R17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1097-0215(1998)78:11+<44::AID-IJC13>3.0.CO;2-A","article-title":"Bone mineral density in long-term survivors of childhood cancer","volume":"11","author":"Hesseling","year":"1998","journal-title":"Int J Cancer"},{"key":"2021122210294563000_R18","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0959-8049(98)00011-2","article-title":"Osteopenia in children surviving brain tumours","volume":"34","author":"Barr","year":"1998","journal-title":"Eur J Cancer"},{"key":"2021122210294563000_R19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00043426-199611000-00006","article-title":"Bone density in survivors of childhood malignancies","volume":"18","author":"Henderson","year":"1996","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021122210294563000_R20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1651-2227.1994.tb13276.x","article-title":"Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy","volume":"399","author":"Nussey","year":"1994","journal-title":"Acta Paediatr"},{"key":"2021122210294563000_R21","first-page":"1168","article-title":"Case Records of the Massachusetts General Hospital: Weekly Clinicopathoogical Exercises: Case 32-2000","volume":"343","author":"Scully","year":"2000","journal-title":"N Engl J Med"},{"key":"2021122210294563000_R22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00043426-200007000-00016","article-title":"Spontaneous humerus fracture and osteoporosis: an unusual presentation of acute lymphoblastic leukemia","volume":"22","author":"Soker","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021122210294563000_R23","first-page":"84a","article-title":"Bone mineral density in children following treatment for acute lymphoblastic leukemia (ALL). Proceedings of the 6th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer","volume-title":"Niagara-on-the-Lake","author":"Halton","year":"2000"},{"key":"2021122210294563000_R24","first-page":"24a","article-title":"Bone mineral density decrements in survivors of childhood ALL: risk factors for its development","volume-title":"Proceedings of the 6th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer","author":"Kaste","year":"2000"},{"key":"2021122210294563000_R25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1203\/00006450-199904010-00014","article-title":"Relative osteopenia after treatment for acute lymphoblastic leukemia","volume":"45","author":"Warner","year":"1999","journal-title":"Pediatr Res"},{"key":"2021122210294563000_R26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2265.1999.00654.x","article-title":"Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia","volume":"50","author":"Hoorweg-Nijman","year":"1999","journal-title":"Clin Endrocrinol"},{"key":"2021122210294563000_R27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00043426-199805000-00009","article-title":"Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia","volume":"20","author":"Arikoski","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021122210294563000_R28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/(SICI)1097-0215(1998)78:11+<35::AID-IJC11>3.0.CO;2-I","article-title":"Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition","volume":"11","author":"Atkinson","year":"1998","journal-title":"Int J Cancer"},{"key":"2021122210294563000_R29","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/jbmr.5650111122","article-title":"Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia","volume":"11","author":"Halton","year":"1996","journal-title":"J Bone Min Res"},{"key":"2021122210294563000_R30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0030-5898(20)32108-8","article-title":"Orthopedic manifestations of acute pediatric leukemia","volume":"27","author":"Gallagher","year":"1996","journal-title":"Orthop Clin North Am"},{"key":"2021122210294563000_R31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0022-3476(95)70349-7","article-title":"Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia","volume":"126","author":"Halton","year":"1995","journal-title":"J Pediatr"},{"key":"2021122210294563000_R32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000204481","article-title":"Severe osteoporosis and multiple vertebral collapses in a child during treatment for B-ALL","volume":"89","author":"D'Angelo","year":"1993","journal-title":"Acta Haematol"},{"key":"2021122210294563000_R33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ajh.2830390213","article-title":"Severe osteopenia and vertebral compression fractures after complete remission in an adolescent with acute leukemia","volume":"39","author":"Vassilopoulou-Sellin","year":"1992","journal-title":"Am J Hematol"},{"key":"2021122210294563000_R34","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0022-3476(89)80138-6","article-title":"Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia","volume":"114","author":"Atkinson","year":"1989","journal-title":"J Pediatr"},{"key":"2021122210294563000_R35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00043426-198823000-00015","article-title":"Destructive skeletal lesions as the primary initial manifestation of acute childhood leukemia","volume":"10","author":"Akber","year":"1988","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"2021122210294563000_R36","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2106\/00004623-198668040-00003","article-title":"Orthopaedic manifestations of leukemia in children","volume":"68","author":"Rogalsky","year":"1986","journal-title":"J Bone Joint Surg"},{"key":"2021122210294563000_R37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-3476(84)80132-8","article-title":"Characteristics of acute lymphoblastic leukemia in children with osteopenia and vertebral compression fractures","volume":"105","author":"Blatt","year":"1984","journal-title":"J Pediatr"},{"key":"2021122210294563000_R38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1148\/107.3.603","article-title":"The Roentgen manifestations of leukemia in infancy","volume":"107","author":"Nixon","year":"1973","journal-title":"Radiology"},{"key":"2021122210294563000_R39","first-page":"863","article-title":"Vertebral compression in childhood leukemia","volume":"125","author":"Newman","year":"1973","journal-title":"Am J Dis Child"},{"key":"2021122210294563000_R40","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/archpedi.1972.02110170031004","article-title":"Childhood acute lymphocytic leukemia: initial radiologic bone involvement and prognosis","volume":"124","author":"Aur","year":"1972","journal-title":"Am J Dis Child"},{"key":"2021122210294563000_R41","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/0003-4819-59-5-637","article-title":"Leukemia with osteoarticular symptoms and signs","volume":"59","author":"Silverstein","year":"1963","journal-title":"Ann Intern Med"},{"key":"2021122210294563000_R42","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/1097-0142(199005\/06)14:3<608::AID-CNCR2820140322>3.0.CO;2-X","article-title":"The skeletal lesions of acute leukemia","volume":"14","author":"Thomas","year":"1961","journal-title":"Cancer"},{"key":"2021122210294563000_R43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/08880019809167227","article-title":"Acute lymphoblastic leukemia with severe skeletal involvement: a subset of childhood leukemia with a good prognosis","volume":"15","author":"Muller","year":"1998","journal-title":"Pediatr Hematol Oncol"},{"key":"2021122210294563000_R44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01241398-199401000-00021","article-title":"The prognostic significance of the skeletal manifestations of acute lymphoblastic leukemia of childhood","volume":"14","author":"Heinrich","year":"1994","journal-title":"J Pediatr Ortho"},{"key":"2021122210294563000_R45","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/adc.52.7.530","article-title":"Prognostic significance of radiological bone involvement in childhood acute lymphoblastic leukaemia","volume":"52","author":"Masera","year":"1977","journal-title":"Arch Dis Child"},{"key":"2021122210294563000_R46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0022-3476(05)80535-9","article-title":"Bone pain as an initial symptom of childhood acute lymphoblastic leukemia: association with nearly normal hematologic indexes","volume":"117","author":"Jonsson","year":"1990","journal-title":"J Pediatr"},{"key":"2021122210294563000_R47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF02388765","article-title":"Absence of prognostic significance of skeletal involvement in acute lymphocytic leukemia and non-Hodgkin lymphoma in children","volume":"15","author":"Appell","year":"1985","journal-title":"Pediatr Radiol"},{"key":"2021122210294563000_R48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mpo.2950060108","article-title":"The prognostic significance of radiological and symptomatic bone involvement in childhood acute lymphoblastic leukaemia","volume":"6","author":"Hann","year":"1979","journal-title":"Med Pediatr Oncol"},{"key":"2021122210294563000_R49","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/1097-0142(19950415)75:8<2186::AID-CNCR2820750825>3.0.CO;2-F","article-title":"Incidence of cancer in children in the United States","volume":"75","author":"Gurney","year":"1995","journal-title":"Cancer"},{"key":"2021122210294563000_R50","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199808273390907","article-title":"Acute lymphoblastic leukemia","volume":"339","author":"Pui","year":"1998","journal-title":"N Engl J Med"},{"key":"2021122210294563000_R51","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0031-3955(05)70532-0","article-title":"Acute lymphoblastic leukemia","volume":"44","author":"Pui","year":"1997","journal-title":"Pediatr Clin North Am"},{"key":"2021122210294563000_R52","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1359\/jbmr.1997.12.11.1761","article-title":"Prevalence of low femoral bone density in older U.S. adults from NHANES III","volume":"12","author":"Looker","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2021122210294563000_R53","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1359\/jbmr.1997.12.11.1769","article-title":"The prevalence of osteoporosis [editorial]","volume":"12","author":"Melton","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2021122210294563000_R54","doi-asserted-by":"crossref","first-page":"369a","DOI":"10.1097\/00043426-200007000-00032","article-title":"Comparative skeletal toxicity of dexamethasone and prednisone in childhood acute lymphoblastic leukemia (ALL)","volume":"22","author":"Halton","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021122210294563000_R55","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/jbmr.5650100608","article-title":"Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3","volume":"10","author":"Scheven","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2021122210294563000_R56","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/mpo.2950230608","article-title":"Methotrexate osteopathy in infants with tumors of the central nervous system","volume":"23","author":"Meister","year":"1994","journal-title":"Med Pediatr Oncol"},{"key":"2021122210294563000_R57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00361126","article-title":"Methotrexate osteopathy","volume":"11","author":"Schwartz","year":"1984","journal-title":"Skeletal Radiol"},{"key":"2021122210294563000_R58","first-page":"139","article-title":"Fractures in children treated with methotrexate for leukemia","volume":"125","author":"Stanisavljevic","year":"1977","journal-title":"Clin Orthop"},{"key":"2021122210294563000_R59","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/1097-0142(197602)37:2+<1048::AID-CNCR2820370811>3.0.CO;2-V","article-title":"Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems","volume":"37","author":"Nesbit","year":"1976","journal-title":"Cancer"},{"key":"2021122210294563000_R60","first-page":"489","article-title":"Methotrexate-induced bone pain in childhood leukemia","volume":"126","author":"O'Reagan","year":"1973","journal-title":"Am J Dis Child"},{"key":"2021122210294563000_R61","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/1097-0142(197003)25:3<580::AID-CNCR2820250313>3.0.CO;2-M","article-title":"Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission","volume":"25","author":"Ragab","year":"1970","journal-title":"Cancer"},{"key":"2021122210294563000_R62","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/1097-0142(197602)37:2+<1162::AID-CNCR2820370827>3.0.CO;2-P","article-title":"Late effects of therapeutic irradiation on the skeleton and bone marrow","volume":"37","author":"Parker","year":"1976","journal-title":"Cancer"},{"key":"2021122210294563000_R63","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3476(05)80536-0","article-title":"Osteoporosis after cranial irradiation for acute lymphoblastic leukemia","volume":"117","author":"Gilsanz","year":"1990","journal-title":"J Pediatr"},{"key":"2021122210294563000_R64","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/adc.67.12.1472","article-title":"Growth hormone deficiency during puberty reduces adult bone mineral density","volume":"67","author":"Hyer","year":"1992","journal-title":"Arch Dis Child"},{"key":"2021122210294563000_R65","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ajcn\/69.5.1014","article-title":"Previous milk consumption is associated with greater bone density in young women","volume":"69","author":"Teegarden","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"2021122210294563000_R66","doi-asserted-by":"crossref","first-page":"406S","DOI":"10.1080\/07315724.1999.10718905","article-title":"The new dietary reference intakes for calcium: implications for osteoporosis","volume":"18","author":"Bryant","year":"1999","journal-title":"J Am Coll Nutr"},{"key":"2021122210294563000_R67","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archpedi.154.6.610","article-title":"Teenaged girls, carbonated beverage consumption, and bone fractures","volume":"154","author":"Wyshak","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2021122210294563000_R68","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archpedi.154.6.542","article-title":"Osteoporosis prevention: a pediatric challenge [editorial]","volume":"154","author":"Golden","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2021122210294563000_R69","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1359\/jbmr.1999.14.2.215","article-title":"Smoking increases bone loss and decreases intestinal calcium absorption","volume":"14","author":"Krall","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2021122210294563000_R70","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1542\/peds.106.1.40","article-title":"Adult hip bone density reflects teenage sports-exercise patterns but not teenage calcium intake","volume":"106","author":"Lloyd","year":"2000","journal-title":"Pediatrics"},{"key":"2021122210294563000_R71","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0022-3476(94)70193-8","article-title":"Influences on skeletal mineralization in children and adolescents: evidence for varying effects of sexual maturation and physical activity","volume":"125","author":"Slemenda","year":"1994","journal-title":"J Pediatr"},{"key":"2021122210294563000_R72","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/jbmr.5650091002","article-title":"Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results","volume":"9","author":"Genant","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2021122210294563000_R73","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF01623825","article-title":"Quality assurance for bone densitometry research studies: concept and impact","volume":"3","author":"Gluer","year":"1993","journal-title":"Osteoporosis Int"},{"key":"2021122210294563000_R74","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1210\/jcem-73-3-555","article-title":"Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence","volume":"73","author":"Bonjour","year":"1991","journal-title":"J Clin Endocrinal Metab"},{"key":"2021122210294563000_R75","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1210\/jcem-70-5-1330","article-title":"Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters","volume":"70","author":"Glastre","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122210294563000_R76","first-page":"245","article-title":"Osteoporosis: new hope for the future","volume":"42","author":"Masi","year":"1997","journal-title":"Int J Fertil"},{"key":"2021122210294563000_R77","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM200008313430902","article-title":"Alendronate for the treatment of osteoporosis in men","volume":"343","author":"Orwoll","year":"2000","journal-title":"N Engl J Med"},{"key":"2021122210294563000_R78","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1073\/pnas.96.1.133","article-title":"Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro","volume":"96","author":"Fisher","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122210294563000_R79","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO;2-U","article-title":"Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis","volume":"42","author":"Hochberg","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2021122210294563000_R80","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/PL00004171","article-title":"Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study","volume":"9","author":"Pols","year":"1999","journal-title":"Osteoporos Int"},{"key":"2021122210294563000_R81","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"339","author":"Saag","year":"1998","journal-title":"N Engl J Med"},{"key":"2021122210294563000_R82","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jama.1997.03540380073035","article-title":"Prevention of nonvertebral fractures by alendronate: a meta-analysis","volume":"227","author":"Karpf","year":"1997","journal-title":"J Am Med Assoc"},{"key":"2021122210294563000_R83","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"2021122210294563000_R84","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"key":"2021122210294563000_R85","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200008033430512","article-title":"Liver damage due to alendronate [letter]","volume":"343","author":"Halabe","year":"2000","journal-title":"N Engl J Med"},{"key":"2021122210294563000_R86","article-title":"In: Physicians Desk Reference 2000","volume-title":"Montvale, NJ Medical Economics Co., 2000;1798-1802.","author":"Alendronate"},{"key":"2021122210294563000_R87","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3810\/pgm.1998.10.445","article-title":"What's new in preventing and treating osteoporosis?","volume":"104","author":"Andrews","year":"1998","journal-title":"Postgrad Med"},{"key":"2021122210294563000_R88","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199708073370603","article-title":"Intermittent etidronate therapy to prevent corticosteroid induced-osteoporosis","volume":"337","author":"Adachi","year":"1997","journal-title":"N Engl J Med"},{"key":"2021122210294563000_R89","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00002512-199813010-00008","article-title":"Risedronate","volume":"13","author":"Goa","year":"1998","journal-title":"Drugs Aging"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.6-3-278","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.6-3-278","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/6\/3\/278\/41837530\/oncolo_6_3_278.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/6\/3\/278\/41837530\/oncolo_6_3_278.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T18:21:51Z","timestamp":1640197311000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/6\/3\/278\/6386854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6,1]]},"references-count":89,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2001,6,1]]},"published-print":{"date-parts":[[2001,6,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.6-3-278","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2001,6,1]]},"published":{"date-parts":[[2001,6,1]]}}}